via The Scientist RSS https://ift.tt/Kh2aoL0 Studies show that a fourth mRNA vaccine dose offers the elderly and other high-risk groups strong protection against hospitalization and death from COVID-19, but experts say benefits for other populations may be more limited. https://ift.tt/Eyf0nhx August 11, 2022 at 09:30PM